G. R. Anderson, R. Lujan, A. Semenov, M. Pravetoni, E. N. Posokhova et al., Expression and localization of RGS9-2/G 5/R7BP complex in vivo is set by dynamic control of its constitutive degradation by cellular cysteine proteases, J Neurosci, vol.27, pp.14117-14127, 2007.

G. R. Anderson, A. Semenov, J. H. Song, and K. A. Martemyanov, The membrane anchor R7BP controls the proteolytic stability of the striatal specific RGS protein, RGS9-2, J Biol Chem, vol.282, pp.4772-4781, 2007.

P. M. Apaja, H. Xu, and G. L. Lukacs, Quality control for unfolded proteins at the plasma membrane, J Cell Biol, vol.191, pp.553-570, 2010.

K. Y. Araki, J. R. Sims, and P. G. Bhide, Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during preand postnatal development, Brain Res, vol.1156, pp.31-45, 2007.

K. Asanuma, Y. Ma, J. Okulski, V. Dhawan, T. Chaly et al., Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation, Neurology, vol.64, pp.347-349, 2005.

B. Balint, A. Vincent, H. M. Meinck, S. R. Irani, and K. P. Bhatia, Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology, Brain, vol.141, pp.13-36, 2018.

J. M. Beaulieu, T. D. Sotnikova, S. Marion, R. J. Lefkowitz, R. R. Gainetdinov et al., An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior, Cell, vol.122, pp.261-273, 2005.

J. M. Beaulieu, T. Del'guidice, T. D. Sotnikova, M. Lemasson, and R. R. Gainetdinov, Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors, Front Mol Neurosci, vol.4, p.38, 2011.

J. M. Beaulieu and R. R. Gainetdinov, The physiology, signaling, and pharmacology of dopamine receptors, Pharmacol Rev, vol.63, pp.182-217, 2011.

G. Bjørkøy, T. Lamark, A. Brech, H. Outzen, M. Perander et al., ) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death, J Cell Biol, vol.171, pp.603-614, 2005.

M. Bourdenx, S. Dovero, M. Engeln, S. Bido, M. F. Bastide et al., Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by a-synuclein overexpression, Acta Neuropathol Commun, vol.3, p.46, 2015.

A. J. Burdette, P. F. Churchill, G. A. Caldwell, and K. A. Caldwell, The early-onset torsion dystonia-associated protein, torsinA, displays molecular chaperone activity in vitro, Cell Stress Chaperones, vol.15, pp.605-617, 2010.

T. M. Cabrera-vera, S. Hernandez, L. R. Earls, M. Medkova, A. K. Sundgren-andersson et al., RGS9-2 modulates D2 dopamine receptor-mediated Ca 2+ channel inhibition in rat striatal cholinergic interneurons, Proc Natl Acad Sci, vol.101, pp.16339-16344, 2004.

M. Carbon, M. Niethammer, S. Peng, D. Raymond, V. Dhawan et al., Abnormal striatal and thalamic dopamine neurotransmission: genotype-related features of dystonia, Neurology, vol.72, pp.2097-2103, 2009.

W. A. Carlezon, V. A. Boundy, C. N. Haile, S. B. Lane, R. G. Kalb et al., Sensitization to morphine induced by viral-mediated gene transfer, Science, vol.277, pp.812-814, 1997.

W. A. Carlezon, E. J. Nestler, and R. L. Neve, Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research, Crit Rev Neurobiol, vol.14, pp.47-67, 2000.

A. Cascalho, J. Jacquemyn, and R. E. Goodchild, Membrane defects and genetic redundancy: are we at a turning point for DYT1 dystonia?, Mov Disord, vol.32, pp.371-381, 2017.

K. Castillo, V. Valenzuela, S. Matus, M. Nassif, M. Oñate et al., Measurement of autophagy flux in the nervous system in vivo, Cell Death Dis, vol.4, p.917, 2013.

J. Celver, M. Sharma, and A. Kovoor, RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors, The Authors EMBO Molecular Medicine, vol.114, pp.9283-2019, 2010.

J. Celver, M. Sharma, and A. Kovoor, D(2)-Dopamine receptors target regulator of G protein signaling 9-2 to detergent-resistant membrane fractions, J Neurochem, vol.120, pp.56-69, 2012.

D. I. Cho, C. Min, K. S. Jung, S. Y. Cheong, M. Zheng et al., The N-terminal region of the dopamine D2 receptor, a rhodopsin-like GPCR, regulates correct integration into the plasma membrane and endocytic routes, Br J Pharmacol, vol.166, pp.659-675, 2012.

R. Coopersmith and R. L. Neve, Expression of multiple proteins within single primary cortical neurons using a replication deficient HSV vector, Biotechniques, vol.27, pp.1156-1160, 1999.

M. T. Dang, F. Yokoi, C. C. Cheetham, J. Lu, V. Vo et al., An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 DGAG knock-in mice, Behav Brain Res, vol.226, pp.465-472, 2012.

B. Dehay, A. Ramirez, M. Martinez-vicente, C. Perier, M. H. Canron et al., Loss of P-type ATPase ATP13A2/ PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration, Proc Natl Acad Sci, vol.109, pp.9611-9616, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01290058

T. Del'guidice, M. Lemasson, and J. M. Beaulieu, Role of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia, Front Neuroanat, vol.25, p.58, 2011.

M. A. Denti, A. Rosa, O. Sthandier, D. Angelis, F. G. Bozzoni et al., A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells, Mol Ther, vol.10, pp.191-199, 2004.

R. M. Drenan, C. A. Doupnik, M. Jayaraman, A. L. Buchwalter, K. M. Kaltenbronn et al., R7BP augments the function of RGS7*Gbeta5 complexes by a plasma membrane-targeting mechanism, J Biol Chem, vol.281, pp.28222-28231, 2006.

B. Ebersole, J. Petko, M. Woll, S. Murakami, K. Sokolina et al., Effect of C-Terminal S-Palmitoylation on D2 dopamine receptor trafficking and stability, PLoS One, vol.10, p.140661, 2015.

E. L. Eskelinen, Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy, Mol Aspects Med, vol.27, pp.495-502, 2006.

S. Fasano, C. Pittenger, and R. Brambilla, Inhibition of CREB activity in the dorsal portion of the striatum potentiates behavioral responses to drugs of abuse, Front Behav Neurosci, vol.9, p.29, 2009.

S. Fasano, E. Bezard, D. 'antoni, A. Francardo, V. Indrigo et al., Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia, Proc Natl Acad Sci, vol.107, pp.21824-21829, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01055134

K. Franklin and G. Paxinos, The mouse brain in stereotaxic coordinates, 2008.

L. M. Giles, J. Chen, L. Li, and L. S. Chin, Dystonia-associated mutations cause premature degradation of torsinA protein and cell-type-specific mislocalization to the nuclear envelope, Hum Mol Genet, vol.17, pp.2712-2722, 2008.

A. H. Gittis and A. C. Kreitzer, Striatal microcircuitry and movement disorders, Trends Neurosci, vol.35, pp.557-564, 2012.

S. J. Gold, C. V. Hoang, B. W. Potts, G. Porras, E. Pioli et al., RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease, J Neurosci, vol.27, pp.14338-14348, 2007.

R. E. Goodchild, C. E. Kim, and W. T. Dauer, Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope, Neuron, vol.48, pp.923-932, 2005.

K. L. Gordon and P. Gonzalez-alegre, Consequences of the DYT1 mutation on torsinA oligomerization and degradation, Neuroscience, vol.157, pp.588-595, 2008.

A. Granata, S. J. Koo, V. Haucke, G. Schiavo, and T. T. Warner, CSN complex controls the stability of selected synaptic proteins via a torsinA-dependent process, EMBO J, vol.30, pp.181-193, 2011.

M. Grillet, D. Gonzalez, B. Sicart, A. Pöttler, M. Cascalho et al., , 2016.

, Torsins are essential regulators of cellular lipid metabolism, Dev Cell, vol.38, pp.235-247

T. Hara, K. Nakamura, M. Matsui, A. Yamamoto, Y. Nakahara et al., Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice, Nature, vol.441, pp.885-889, 2006.

A. S. Hauser, M. M. Attwood, M. Rask-andersen, H. B. Schiöth, and D. E. Gloriam, Trends in GPCR drug discovery: new agents, targets and indications, Nat Rev Drug Discov, vol.16, pp.829-842, 2017.

T. Johansen and T. Lamark, Selective autophagy mediated by autophagic adapter proteins, Autophagy, vol.7, pp.279-296, 2011.

K. M. Kim, K. J. Valenzano, S. R. Robinson, W. D. Yao, L. S. Barak et al., Differential regulation of the dopamine D2 and D3 receptors by G proteincoupled receptor kinases and beta-arrestins, J Biol Chem, vol.276, pp.37409-37414, 2001.

D. S. Kim, G. J. Froelick, and R. D. Palmiter, Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum, J Neurosci, vol.22, pp.9841-9849, 2002.

M. Komatsu and Y. Ichimura, Physiological significance of selective degradation of p62 by autophagy, FEBS Lett, vol.584, pp.1374-1378, 2010.

A. Kovoor, P. Seyffarth, J. Ebert, S. Barghshoon, C. K. Chen et al., D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways, J Neurosci, vol.25, pp.2157-2165, 2005.

Y. Li, B. D. Roy, W. Wang, L. Zhang, L. Zhang et al., Identification of two functionally distinct endosomal recycling pathways for dopamine D 2 receptor, J Neurosci, vol.32, pp.7178-7190, 2012.

A. Lilienbaum, Relationship between the proteasomal system and autophagy, Int J Biochem Mol Biol, vol.4, pp.1-26, 2013.

J. A. Macgurn, Garbage on, garbage off: new insights into plasma membrane protein quality control, Curr Opin Cell Biol, vol.29, pp.92-98, 2014.

G. Mandolesi, E. Autuori, R. Cesa, F. Premoselli, P. Cesare et al., GluRdelta2 expression in the mature cerebellum of hotfoot mice promotes parallel fiber synaptogenesis and axonal competition, PLoS One, vol.4, p.5243, 2009.

G. Martella, M. Maltese, R. Nisticò, T. Schirinzi, G. Madeo et al., Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia, Neurobiol Dis, vol.65, pp.124-132, 2014.

I. Masuho, H. Wakasugi-masuho, E. N. Posokhova, J. R. Patton, and K. A. Martemyanov, Type 5 G protein beta subunit (Gbeta5) controls the interaction of regulator of G protein signaling 9 (RGS9) with membrane anchors, J Biol Chem, vol.286, pp.21806-21813, 2011.

S. Matus, V. Valenzuela, and C. Hetz, A new method to measure autophagy flux in the nervous system, Autophagy, vol.10, pp.710-714, 2014.

S. A. Mcdougall, S. E. Eaton, A. Mohd-yusof, and C. A. Crawford, Age-dependent changes in cocaine sensitivity across early ontogeny in male and female rats: possible role of dorsal striatal D2(High) receptors, Psychopharmacology, vol.232, pp.2287-2301, 2015.

F. Napolitano, M. Pasqualetti, A. Usiello, E. Santini, G. Pacini et al., Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia, Neurobiol Dis, vol.38, pp.434-445, 2010.

L. J. Ozelius, J. W. Hewett, C. E. Page, S. B. Bressman, P. L. Kramer et al., The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein, Nat Genet, vol.17, pp.40-48, 1997.

Y. K. Peterson and L. M. Luttrell, The diverse roles of arrestin scaffolds in g protein-coupled receptor signaling, Pharmacol Rev, vol.69, pp.256-297, 2017.

A. Pisani, G. Martella, A. Tscherter, P. Bonsi, N. Sharma et al., Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia, Neurobiol Dis, vol.24, pp.318-325, 2006.

G. Ponterio, A. Tassone, G. Sciamanna, V. Vanni, M. Meringolo et al., Enhanced mu opioid receptordependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia, Mov Disord, vol.33, pp.310-320, 2018.

M. Pratelli, S. Migliarini, B. Pelosi, F. Napolitano, A. Usiello et al., Perturbation of serotonin homeostasis during adulthood affects serotonergic neuronal circuitry, vol.4, pp.376-392, 2017.

Z. Rahman, J. Schwarz, S. J. Gold, V. Zachariou, M. N. Wein et al., RGS9 modulates dopamine signaling in the basal ganglia, vol.38, pp.941-952, 2003.

P. Redgrave, M. Rodriguez, Y. Smith, M. C. Rodriguez-oroz, S. Lehericy et al., Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease, Nat Rev Neurosci, vol.11, pp.760-772, 2010.

M. Scarduzio, C. N. Zimmerman, K. L. Jaunarajs, Q. Wang, D. G. Standaert et al., Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia, Exp Neurol, vol.295, pp.162-175, 2017.

G. Sciamanna, A. Tassone, G. Martella, G. Mandolesi, F. Puglisi et al., Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia, PLoS One, vol.6, p.24261, 2011.

G. Sciamanna, R. Hollis, C. Ball, G. Martella, A. Tassone et al., Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA, Neurobiol Dis, vol.47, pp.416-427, 2012.

G. Sciamanna, A. Tassone, G. Mandolesi, F. Puglisi, G. Ponterio et al., Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia, J Neurosci, vol.32, pp.11991-12004, 2012.

P. Seeman, F. Ko, E. Jack, R. Greenstein, and B. Dean, Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain, Synapse, vol.61, pp.303-309, 2007.

B. Sjögren, The evolution of regulators of G protein signaling proteins as drug targets -20 years in the making: IUPHAR Review 21, Br J Pharmacol, vol.174, pp.427-437, 2017.

F. D. Smith, G. S. Oxford, and S. L. Milgram, Association of the D2 dopamine receptor third cytoplasmic loop with spinophilin, a protein phosphatase-1-interacting protein, J Biol Chem, vol.274, pp.19894-19900, 1999.

J. H. Song, J. J. Waataja, and K. A. Martemyanov, Subcellular targeting of RGS9-2 is controlled by multiple molecular determinants on its membrane anchor, R7BP, J Biol Chem, vol.281, pp.15361-15369, 2006.

I. Tanida, N. Minematsu-ikeguchi, T. Ueno, and E. Kominami, Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy, Autophagy, vol.1, pp.84-91, 2005.

I. Tanida, T. Ueno, and E. Kominami, LC3 and autophagy, Methods Mol Biol, vol.445, pp.77-88, 2008.

M. F. Tansky, C. Pothoulakis, and S. E. Leeman, Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor, 2007.

, Proc Natl Acad Sci, vol.104, pp.10691-10696

G. E. Torres, A. L. Sweeney, J. M. Beaulieu, P. Shashidharan, and M. G. Caron, Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant, Proc Natl Acad Sci, vol.101, pp.15650-15655, 2004.

J. R. Traynor, D. Terzi, B. J. Caldarone, and V. Zachariou, RGS9-2: probing an intracellular modulator of behavior as a drug target, Trends Pharmacol Sci, vol.30, pp.105-111, 2009.

N. M. Urs, S. Bido, S. M. Peterson, T. L. Daigle, C. E. Bass et al., Targeting b-arrestin2 in the treatment of L-DOPAinduced dyskinesia in Parkinson's disease, Proc Natl Acad Sci, vol.112, pp.2517-2526, 2015.

V. Vanni, F. Puglisi, P. Bonsi, G. Ponterio, M. Maltese et al., Cerebellar synaptogenesis is compromised in mouse models of DYT1 dystonia, Exp Neurol, vol.271, pp.457-467, 2015.

Q. Wang, J. Zhao, A. E. Brady, J. Feng, P. B. Allen et al., Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors, Science, vol.304, pp.1940-1944, 2004.

F. Yokoi, M. T. Dang, J. Li, D. G. Standaert, and Y. Li, Motor deficits and decreased striatal dopamine receptor 2 binding activity in the striatum-specific Dyt1 conditional knock-out mice, PLoS One, vol.6, p.24539, 2011.

B. Y. Zeng, S. J. Heales, L. Canevari, S. Rose, and P. Jenner, Alterations in expression of dopamine receptors and neuropeptides in the striatum of GTP cyclohydrolase-deficient mice, Exp Neurol, vol.190, pp.515-524, 2004.

M. Zheng, S. Y. Cheong, M. C. , J. M. Cho, D. I. Kim et al., ) b-arrestin2 plays permissive roles in the inhibitory activities of RGS9-2 on G proteincoupled receptors by maintaining RGS9-2 in the open conformation, Mol Cell Biol, vol.31, pp.4887-4901, 2011.

M. Zheng, X. Zhang, N. N. Sun, C. Min, X. Zhang et al., RalA employs GRK2 and b-arrestins for the filamin A-mediated regulation of trafficking and signaling of dopamine D2 and D3 receptor, Biochim Biophys Acta, vol.1863, pp.2072-2083, 2016.

, License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited, The Authors EMBO Molecular Medicine, vol.11, pp.9283-2019, 2018.